The immunohistochemical expression of c-MET and RON in lung adenocarcinoma with clinicopathologic correlation

被引:1
|
作者
Kim, Young-Ah [1 ,2 ]
Sung, Woo Jung [1 ]
机构
[1] Daegu Catholic Univ, Dept Pathol, Sch Med, Duryugongwon ro 17 gil 33, Daegu 42472, South Korea
[2] Seoul Clin Labs Daegu, 95 Hwarang ro, Daegu 41238, South Korea
关键词
c-MET; lung adenocarcinoma; non-small cell lung cancer; RON; RECEPTOR TYROSINE KINASE; COPY NUMBER; CANCER; AMPLIFICATION; OVEREXPRESSION; PROGRESSION; ACTIVATION; RESISTANCE; GEFITINIB; PATHWAY;
D O I
10.4103/ijpm.ijpm_358_22
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background:Mesenchymal epidermal transition (MET) and receptor originating from nantes (RON) are transmembrane tyrosine kinase receptors. Both are members of a proto-oncogene family and thus play a role in the pathogenesis of various cancers and acquired resistance to kinase inhibitors in lung cancer.Aims:The aim of this study was to investigate the immunohistochemical expression of c-MET and RON in lung adenocarcinoma and its clinicopathologic correlation.Settings and Design:Retrospective study.Materials and Methods:The immunohistochemical c-MET and RON expression in specimens obtained from lung adenocarcinoma (n = 175) and associated clinicopathologic parameters were evaluated.Statistical Analysis Used:The correlation between c-MET and RON expression was analyzed by Chi-square test. A Cox proportional hazards model and Kaplan-Meier curve analysis were used to evaluate the risk factors and prognosis.Results:High expression of the c-MET protein showed a strong correlation with that of RON (P = 0.013, kappa = 0.183). Five-year survival and recurrence-free 5-year survival were not associated with high expression of c-MET or RON. High c-MET expression was significantly associated with age older than 60 years (P = 0.000), tumor differentiation (P = 0.009), lymphovascular invasion (P = 0.016), and pleural invasion (P = 0.005). High RON expression was associated with a solid growth pattern (P = 0.001) and pleural invasion (P = 0.002).Conclusions:The results point to the potential of immunohistochemical expression of c-MET and RON as useful prognostic markers of unfavorable histopathologic features in lung adenocarcinoma.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [41] Identification and characterization of a novel RON/c-Met small molecule inhibitor
    Zhang, Yihong
    Kaplan-Lefko, Paula J.
    Rex, Karen
    Yang, Yajing
    Moriguchi, Jodi
    Osgood, Tao
    Mattson, Bethany
    Coxon, Angela
    Burgess, Teresa L.
    Dussault, Isabelle
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3408S - 3409S
  • [42] Prevalence of c-Met overexpression (c-Met plus ) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
    Motwani, M.
    Panchabhai, S.
    Bar, J.
    Girard, N.
    Bradbury, P.
    Lu, S.
    Jin, J.
    Hotson, A.
    Maag, D.
    Planchard, D.
    Camidge, D. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1169 - S1170
  • [43] IMMUNOHISTOCHEMICAL EXPRESSION OF HEPATOCYTE GROWTH FACTOR/c-MET IN THE HEART AND AORTA OF DIABETIC RATS
    Tekmen, I.
    Micili, S. Cilaker
    Arici, M. A.
    Guneli, M. E.
    Gumustekin, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2014, 10 (01) : 21 - 30
  • [44] Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study
    Nabeshima, K
    Shimao, Y
    Sato, S
    Kataoka, H
    Moriyama, T
    Kawano, H
    Wakisaka, S
    Koono, M
    HISTOPATHOLOGY, 1997, 31 (05) : 436 - 443
  • [45] Expression of c-MET in invasive meningioma
    Yun, S.
    Koh, J.
    Lee, K.
    Seo, A.
    Nam, K.
    Choe, G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 174 - 174
  • [46] Expression of c-Met in laryngeal carcinoma
    M. Sawatsubashi
    Eizaburo Sasatomi
    Hiroyuki Mizokami
    Osamu Tokunaga
    Takemoto Shin
    Virchows Archiv, 1998, 432 : 331 - 335
  • [47] Expression of c-Met in laryngeal carcinoma
    Sawatsubashi, M
    Sasatomi, E
    Mizokami, H
    Tokunaga, O
    Shin, T
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (04): : 331 - 335
  • [48] C-MET EXPRESSION IN MALIGNANT MESOTHELIOMAS
    Illei, Peter
    Sharma, Rajni
    Cowan, Morgan
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S804 - S804
  • [49] Expression of c-MET in Invasive Meningioma
    Yun, Sumi
    Koh, Jae Moon
    Lee, Kyu Sang
    Seo, An Na
    Nam, Kyung Han
    Choe, Gheeyoung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2015, 49 (01) : 44 - 51
  • [50] Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: A clinicopathologic and immunohistochemical study
    Oda, Y
    Naka, T
    Takeshita, M
    Iwamoto, Y
    Tsuneyoshi, M
    HUMAN PATHOLOGY, 2000, 31 (06) : 709 - 716